Session Information
Session Type: Abstract Submissions (ACR)
Background/Purpose: Bone and cartilage loss and destruction is associated with rheumatoid arthritis (RA) and inflammation. There is a need for tools for prediction of potential severe patients with poor outcome. The BMA device (D3ATM Medical Systems, Orleans, France) is a high resolution X-ray technique, used to image bone and joints, and to measure bone texture parameters including the fractal dimension (Hmean). The aims of this study were to evaluate, by BMA analysis, the metacarpal bone texture in a cohort of 165 RA patients after 1 year of follow up, and to assess the relationship between these parameters and RA disease parameters at baseline and over 1 year.
Methods: Patients with RA according to ACR criteria were included. They were assessed every 6 months over 1 year, in the context of a prospective study conducted in Maastricht. For this substudy, activity of the disease was assessed by erythrocyte sedimentation rate (ESR), C reactive protein (CRP) and Disease Activity Score (DAS 28) performed at each visit. Radiographic bone damage is assessed using hand and feet conventional posterior-anterior radiographs at baseline and on a 1-year basis The bone texture parameters were evaluated on the second and third metacarpal heads of the left hand (MCP2 and MCP3) using BMA device, with standard acquisition at baseline, 6 and 12 months. A single investigator performed all the analyses, with standardized position of regions of interest in the bones. The calculated parameter was Hmean as an approach to bone roughness.
Results: 165 patients were included 57 men and 108 women, mean age 63.63 years [33-89]. The mean disease duration was 9.67 years [2-36]. Among the 138 cases where rheumatoid factor results were available, 75 were positive and among the 11 cases where anti CCP antibodies were available only 6 were positive. 53 patients were followed using BMA device and a total of 632 joints were studied. 24/53 (45.3%) patients had RA damage (erosions, joint space narrowing). The mean DAS28 score was 3.34 [0.63-7.35]. Twenty four patients were receiving bisphosphonate during the study. Hmean was similar in MCP2 and MCP3 at baseline: 0.411±0.038 and 0.412±0.043 respectively; H mean MCP2 was correlated with disease duration (-0.17, p=0.03). There was an increase in H mean MCP2 (+ 1.0 % p=0.0004) over 1 year. ESR and CRP were correlated with H mean MCP3 at baseline (-0,15, p=0.055; -0.15 p=0.06) and 6 months (-0.22 p=0.006, -0.25 p=0.002 respectively). DAS was correlated with H mean MCP3 at 6 months (-0.14, p=0.07) and H mean MCP2 at 12 months (-0.16 p=0.04).
Conclusion: This new high resolution digital X-ray device provides bone texture parameters of metacarpal heads in RA patients. This preliminary analysis suggests that these parameters measured at the metacarpal heads are influenced by disease duration and activity.
Disclosure:
L. Sparsa,
None;
S. Kolta,
None;
K. Briot,
None;
S. Paternotte,
None;
R. Masri,
None;
D. Loeuille,
None;
P. P. Geusens,
None;
C. Roux,
None.
« Back to 2012 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/prospective-assessement-of-bone-texture-parameters-at-the-hand-in-rheumatoid-arthritis/